Medical Devices

In two years, XERF has dominated the skin tightening market. We explore the strategy, tech, and cultural shift behind its meteoric, resilient rise.

An EY award for Rhythm Express founders highlights a deeper story of strategic innovation, patient-centric design, and the future of remote health monitoring.

A neurotech startup just hired a 20-year Cigna veteran. It’s not just a new advisor; it's a bold strategy to crack the insurance code for mental health.

For decades, newborns with a common foot condition faced painful casting. Now, a simple, FDA-approved brace is disrupting pediatric care and bringing relief.

A new deal between Parker Labs and Premier Inc. isn't just business. It's a critical look at how GPOs and new tech dictate infection control for millions.

Access Vascular and Medline are betting on a new hydrogel catheter to cut costly complications. Can this blend of advanced biomaterials and scale change care?

Teleflex launches a pivotal trial for a magnesium stent that vanishes in a year. Can it erase the memory of past failures and redefine cardiovascular care?

BD's new contract with purchasing giant Vizient for its CentroVena One™ system isn't just a product win; it's a strategic maneuver to redefine market standards.

With a $43M funding boost, Irish innovator CroíValve is expanding trials for its unique 'Adaptive Coaptation' device, aiming to transform treatment for millions.

In just two years, WONTECH ASIA hit THB 1B in revenue, seizing 40% of Thailand's RF device market. This is a masterclass in commercialization strategy.

PorTal Access wins FDA clearance for FLEXI-PORT™, a device poised to disrupt a stagnant market by focusing on patient comfort and clinical versatility.

Polish startup MY OVU wins a coveted spot at CES 2027. Its intelligent thermometer signals a new era for women's health and European tech innovation.

SINTX Technologies secures orders worth triple its annual revenue, showcasing a savvy dual strategy where manufacturing funds its ambitious medical device pipeline.

SeaStar Medical prepares to present its life-saving organ failure technology to investors. We explore its newly approved product, pivotal adult trial, and vast market potential.

Vivos Therapeutics gets more time from its lender to raise capital, a crucial move as it navigates Nasdaq compliance issues and funds a major business overhaul.

GuideAI Health's new AI software, which scans for peripheral vascular disease, promises to slash diagnosis times and prevent amputations for millions.

Masimo's FDA-cleared AI monitor for opioid risk does more than track vitals; it predicts danger, pushing healthcare from reactive alarms to proactive intervention.

Sisram Medical's strategic rollout of advanced devices and injectables in Thailand is more than an expansion; it's a calculated move to dominate APAC's booming beauty market.

In a bold pivot, digital health firm Davion Healthcare is ditching a $120M licensing deal to build its own distribution network. Is this visionary control or a costly gamble?